GATA3 and rheumatoid arthritis: By comparing the methylation levels of whole blood samples of patients with RA who had a good or bad response to MTX therapy for weeks, it was found that the differential methylation sites related to MTX therapy were mainly near GATA3 (cg27427581), RPH3AL(cg21040096), and WDR27(cg09894276) (52).